Biodel (BIOD), Albireo Enter Merger Agreement
Key Points:Transaction to result in NASDAQ-listed company focused in orphan pediatric liver diseasesAlbireo brings wholly owned, Phase 2 lead asset ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)